Comparative Effectiveness of Up To Three Lines of Chemotherapy Treatment Plans for Metastatic Colorectal Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative Effectiveness of Up To Three Lines of Chemotherapy Treatment Plans for Metastatic Colorectal Cancer

Published:2017-07 Issue:2 Volume:2 Page:238146831772965
ISSN:2381-4683
Container-title:MDM Policy & Practice
language:en
Short-container-title:MDM Policy & Practice

Author:

Toumazis Iakovos¹²³⁴,Kurt Murat¹²³⁴,Toumazi Artemis¹²³⁴,Karacosta Loukia G.¹²³⁴,Kwon Changhyun¹²³⁴

Affiliation:

1. Department of Radiology, Stanford University, Stanford, California (IT, LGK)

2. Economic and Data Sciences, Merck Research Labs, North Wales, Pennsylvania (MK)

3. Cordeliers Research Center, Paris, France (AT)

4. Department of Industrial & Management Systems Engineering, University of South Florida, Tampa, Florida (CK)

Publisher

SAGE Publications

Subject

Public Health, Environmental and Occupational Health,Health Policy

Link

http://journals.sagepub.com/doi/pdf/10.1177/2381468317729650

Reference50 articles.

1. Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

2. A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

3. Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Patients With Late-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline;JCO Global Oncology;2020-11

2. Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data;PharmacoEconomics;2020-08-17

3. Health Economic Models for Metastatic Colorectal Cancer: A Methodological Review;PharmacoEconomics;2020-04-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3